Ameloblastomas, first discovered in 1827, are tumors that originate from the remnants of dental enamel or epithelium. Unlike other tumors, ameloblastomas develop outside the bone and can spread to the jaw and the surrounding tissue, including the tongue. These growths can cause tooth displacement and difficulty in chewing as they produce osteoclasts. While most ameloblastomas are non-cancerous, some can exhibit aggressive growth, leading to facial asymmetry and functional impairment of nearby tissues and organs. Ameloblastomas make up approximately 11 percent of jaw cysts and 1 percent of all head and neck tumors.
Who is Affected?
Ameloblastomas primarily affect individuals in the age range of 30 to 40 years old. Research indicates that maxillary ameloblastomas, which occur in the upper jaw, are more prevalent in older individuals, whereas other types tend to develop in younger people. Certain studies investigate the potential influence of ethnicity or race, as there have been claims of increased occurrences among black and Asian populations.
Causes of Ameloblastomas
Ameloblastomas are a type of oral tumor, the exact cause of which has not been definitively identified by researchers. However, several theories have been proposed to explain their development.
One theory suggests that impacted or unerupted teeth may play a role in the formation of oral cysts and tumors, including ameloblastomas. When teeth fail to properly emerge from the gums, they can cause disruptions in the surrounding tissues, potentially leading to the development of abnormal growths.
Researchers are also exploring the potential link between ameloblastomas and the human papillomavirus (HPV). Certain strains of HPV have been associated with an increased risk of developing tumors, and ongoing studies are investigating whether there is a similar connection with ameloblastomas.
Additionally, a study has proposed that low levels of the p53 gene could contribute to the development of ameloblastomas. The p53 gene is responsible for regulating the cell cycle and suppressing the formation of tumors. If the levels of this gene are insufficient, it may increase the likelihood of tumor growth.